pharma · Chronic Immune Thrombocytopenia (ITP)
Kedrion
Kedrion S.p.A.
Kedrion S.p.A is a pharma organization headquartered in BARGA, IT. Primary therapeutic focus areas include Chronic Immune Thrombocytopenia (ITP). NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 paten
Barga, IT HQ
2,667 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Barga, IT
- Employees
- 2,667
- Programs
- 1
- Drugs
- 0
- Patents
- 0
KIg10
Phase 3 · small molecule · Chronic Immune Thrombocytopenia (ITP)
KIg10 for Chronic Immune Thrombocytopenia (ITP) is a Phase 3 program (small_molecule) at Kedrion S.p.A. with 1 ClinicalTrials.gov record(s).
Internal code KB072
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Kedrion S.p.A.
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Chronic Immune Thrombocytopenia (ITP)
- Status
- active
- Trials
- 1